Français
ItalianoBond Amgen 3% ( US031162DD92 ) in USD
| Issuer | Amgen | ||||||||
| Market price |  96.80 % ▼ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US031162DD92 ( in USD )
|
||||||||
| Interest rate | 3% per year ( payment 2 times a year) | ||||||||
| Maturity | 22/02/2029 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 031162DD9 | ||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||
| Next Coupon | 22/02/2027 ( In 161 days ) | ||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DD92, pays a coupon of 3% per year. The coupons are paid 2 times per year and the Bond maturity is 22/02/2029 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DD92, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DD92, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||